Reply to M.B. Abid.

Authors :: Santomasso B
Ghosh M
Schneider B
Bollin K
Source :: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 May 01; Vol. 40 (13), pp. 1509. Date of Electronic Publication: 2022 Mar 04.
Publication Year :: 2022
Abstract: Competing Interests: Bianca SantomassoConsulting or Advisory Role: Celgene, Janssen, Legend Biotech, Incyte, In8BioResearch Funding: ADC Therapeutics (Inst) Monalisa GhoshResearch Funding: Novartis (Inst), Celgene (Inst) Bryan SchneiderResearch Funding: Merck Kathryn BollinConsulting or Advisory Role: Iovance BiotherapeuticsNo other potential conflicts of interest were reported.

Language :: English
ISSN :: 1527-7755
Volume :: 40
Issue :: 13
Database :: MEDLINE
Journal :: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication Type :: Report
Accession number :: 35245095
Full Text :: https://doi.org/10.1200/JCO.22.00225